Stay updated with breaking news from Trial Name. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval was based on the QUILT-3.032 study, which included 77 adults with carcinoma in situ with or without papillary tumors after a transurethral resection.
Tigilanol tiglate is a novel, small molecule drug for the intratumoral treatment of solid tumors, inducing tumor cell death and stimulating immune response.
In a phase 3 trial, none of the patients receiving nirogacestat reached median progression-free survival, indicating that it may effectively reduce disease progression.
Major barriers to care for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) can include navigating therapeutics and the cost of medications.
The Outlast Trials has received update 3 with a new trial being added, new challenges, and the time limited Halloween event Project Geister. There has